Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heike Wulff

Showing results (191-200 of 222) with videos related to

Pageof 23
Sort By:
Archives of Toxicology|April 3, 2020
Comparison of the toxicokinetics of the convulsants picrotoxinin and tetramethylenedisulfotetramine (TETS) in miceBrandon Pressly, Natalia Vasylieva, Bogdan Barnych, et al.
The Journal of Clinical Investigation|August 9, 2008
The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humansKazuyoshi Toyama, Heike Wulff, K George Chandy, et al.
Molecular & Cellular Proteomics : MCP|June 27, 2024
Proximity Labeling Proteomics Reveals Kv1.3 Potassium Channel Immune Interactors in MicrogliaChristine A Bowen, Hai M Nguyen, Young Lin, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
KCa3.1 Contributes to Neuroinflammation and Nigral Dopaminergic Neurodegeneration in Experimental models of Parkinson's DiseaseManikandan Samidurai, Karthick Chennakesavan, Souvarish Sarkar, et al.
Pharmacological Research|November 11, 2019
SKA-31, an activator of Ca<sup>2+</sup>-activated K<sup>+</sup> channels, improves cardiovascular function in agingCini Mathew John, Rayan Khaddaj Mallat, Ramesh C Mishra, et al.
Circulation|August 27, 2003
Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosisRalf Köhler, Heike Wulff, Ines Eichler, et al.
Circulation|April 22, 2009
Genetic deficit of SK3 and IK1 channels disrupts the endothelium-derived hyperpolarizing factor vasodilator pathway and causes hypertensionSebastian Brähler, Anuradha Kaistha, Volker J Schmidt, et al.
Journal of Molecular and Cellular Cardiology|June 1, 2021
Molecular determinants of pro-arrhythmia proclivity of d- and l-sotalol via a multi-scale modeling pipelineKevin R DeMarco, Pei-Chi Yang, Vikrant Singh, et al.
Angewandte Chemie (International Ed. in English)|February 27, 2025
Photoisomerization of Azobenzene-Extended Charybdotoxin for the Optical Control of K<sub>v</sub>1.2 Potassium Channel ActivityYanis Achouba, Basile Peres, Steven Ascoet, et al.
Nature Communications|April 17, 2025
Cryo-EM structures of the small-conductance Ca<sup>2+</sup>-activated K<sub>Ca</sub>2.2 channelYoung-Woo Nam, Dohyun Im, Ana Santa Cruz Garcia, et al.
Pageof 23

Showing results (191-200 of 222) with videos related to

Sort By:
Pageof 23
Archives of Toxicology|April 3, 2020
Comparison of the toxicokinetics of the convulsants picrotoxinin and tetramethylenedisulfotetramine (TETS) in miceBrandon Pressly, Natalia Vasylieva, Bogdan Barnych, et al.
The Journal of Clinical Investigation|August 9, 2008
The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humansKazuyoshi Toyama, Heike Wulff, K George Chandy, et al.
Molecular & Cellular Proteomics : MCP|June 27, 2024
Proximity Labeling Proteomics Reveals Kv1.3 Potassium Channel Immune Interactors in MicrogliaChristine A Bowen, Hai M Nguyen, Young Lin, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
KCa3.1 Contributes to Neuroinflammation and Nigral Dopaminergic Neurodegeneration in Experimental models of Parkinson's DiseaseManikandan Samidurai, Karthick Chennakesavan, Souvarish Sarkar, et al.
Pharmacological Research|November 11, 2019
SKA-31, an activator of Ca<sup>2+</sup>-activated K<sup>+</sup> channels, improves cardiovascular function in agingCini Mathew John, Rayan Khaddaj Mallat, Ramesh C Mishra, et al.
Circulation|August 27, 2003
Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosisRalf Köhler, Heike Wulff, Ines Eichler, et al.
Circulation|April 22, 2009
Genetic deficit of SK3 and IK1 channels disrupts the endothelium-derived hyperpolarizing factor vasodilator pathway and causes hypertensionSebastian Brähler, Anuradha Kaistha, Volker J Schmidt, et al.
Journal of Molecular and Cellular Cardiology|June 1, 2021
Molecular determinants of pro-arrhythmia proclivity of d- and l-sotalol via a multi-scale modeling pipelineKevin R DeMarco, Pei-Chi Yang, Vikrant Singh, et al.
Angewandte Chemie (International Ed. in English)|February 27, 2025
Photoisomerization of Azobenzene-Extended Charybdotoxin for the Optical Control of K<sub>v</sub>1.2 Potassium Channel ActivityYanis Achouba, Basile Peres, Steven Ascoet, et al.
Nature Communications|April 17, 2025
Cryo-EM structures of the small-conductance Ca<sup>2+</sup>-activated K<sub>Ca</sub>2.2 channelYoung-Woo Nam, Dohyun Im, Ana Santa Cruz Garcia, et al.
Pageof 23